Condiciones de salud que junco dulce puede ayudar a apoyar.
A. calamus extracts display significant free radical scavenging and antioxidant enzyme-modulating activity in vitro and in animal models. PMC studies confirm elevation of SOD, catalase, and glutathione activity. Multiple published biochemical studies (2023–2024) confirm antioxidant activity in leaf and rhizome extracts.
Preclinical animal studies demonstrate anxiolytic effects of A. calamus extracts, and a small open-label human trial (n=33) using 500 mg twice daily of a hydroethanolic extract over 60 days reported reductions in anxiety ratings. The active constituents α- and β-asarone are thought to modulate GABAergic pathways. No large randomized controlled trials exist.
A. calamus rhizome extract has demonstrated bronchodilatory activity in preclinical models through multiple pathways. A 2010 PubMed-indexed Journal of Ethnopharmacology study confirmed bronchodilatory effects. Traditional use in asthma across Ayurveda, Unani, and Chinese medicine is extensively documented.
A. calamus extract demonstrates antihypertensive and coronary vasodilatory effects in preclinical models. A 2012 PubMed study in bovine coronary arterial preparations showed the extract causes cardiac depressant and EDHF-mediated coronary vasodilation via potassium channel activation. Traditional use for vascular disorders is documented.
Multiple preclinical studies demonstrate antidiabetic activity of A. calamus extract in STZ-induced and genetically diabetic (db/db) mouse models, through mechanisms including α-glucosidase inhibition, insulin sensitization, and GLP-1 modulation. Traditional use for diabetes is documented in American, Indonesian, and Ayurvedic folk medicine.
A. calamus extracts exhibit CNS-depressant, sedative, and tranquilizing effects demonstrated in multiple animal models. These properties are attributed to asarone constituents' action on GABAergic pathways. Traditional classification as a nervous system calming agent is well-established in Ayurveda and multiple ethnomedicinal systems.
Preclinical studies consistently show A. calamus reduces total cholesterol and LDL in diabetic and normal animal models. A small clinical study in ischemic heart disease patients reported decreased serum cholesterol. The 2013 pharmacological review lists 'hypolipidemic' among validated A. calamus activities.
A. calamus demonstrates significant anti-inflammatory activity in multiple animal models, with identified mechanisms including NF-κB inhibition, prostaglandin suppression, and inflammatory cytokine reduction. PMC studies confirm anti-inflammatory, anti-oxidative, and calcium-inhibitory effects in neuropathic pain models.
A. calamus extracts show AChE inhibitory activity relevant to Alzheimer's pathology, neuroprotective effects in ischemia models, and antioxidant activity that may combat age-related neurodegeneration. Traditional use as a brain rejuvenator (medhya rasayana) spans millennia. No human RCTs targeting cognitive decline have been completed.
Multiple animal studies confirm antidepressant activity of A. calamus rhizome extract via serotonergic and antioxidant mechanisms. An Ayurvedic journal clinical study referenced in the literature assessed Vacha in depressive illness. Preclinical evidence is strong; independent human RCT data are lacking.
A. calamus has traditional use across multiple cultures for diarrhea and dysentery, with a pharmacological basis established via calcium channel blockade antispasmodic mechanisms. A 2006 Phytotherapy Research study confirmed antidiarrhoeal and antispasmodic activity in animal gut preparations.
A. calamus rhizome has documented anticonvulsant activity in multiple animal seizure models, including the Maximal Electro Shock model, with effects compared directly to phenytoin. Traditional use for epilepsy in Ayurveda, Chinese medicine, and Indian tribal communities is extensively documented.
Rat studies have shown A. calamus rhizome extract has inhibitory action on gastric secretion and antiulcerogenic activity, providing a preclinical basis for traditional use in gastritis. Traditional Ayurvedic and Unani use for gastric complaints is well-documented, though human clinical trial data are absent.
Animal studies (PMC, 2021) demonstrate nephroprotective activity of A. calamus, with improved urinary creatinine clearance, GFR, and histopathological kidney protection. Traditional use for kidney troubles is consistently documented across Ayurvedic and Unani systems.
Animal studies confirm hepatoprotective activity of A. calamus extract, including amelioration of alcohol-induced hepatotoxicity and normalization of liver enzyme markers. A 2021 PMC mouse study demonstrated hepatoprotective and nephroprotective activity with histopathological and biochemical confirmation.
A. calamus has documented acetylcholinesterase inhibitory activity and memory-enhancing effects in animals. A small clinical study in children (Ayushdhara journal) found significant memory improvement with 250 mg Vacha rhizome twice daily over 48–96 days. Traditional Ayurvedic use for memory loss is among its oldest documented applications.
Animal studies show A. calamus counters stress-induced neurochemical changes, including oxidative imbalance and cortisol dysregulation. A referenced human open-label trial assessed its role in stress-related symptoms using standardized psychological scales. Traditional use as an adaptogenic nervine is well-documented in Ayurveda.
Animal studies confirm hypolipidemic activity of A. calamus including reduction in serum triglycerides. A PubMed-indexed rat study (2002) showed significant hypolipidemic activity with ethanolic extract and isolated saponins. Triglyceride-lowering was replicated in db/db diabetic mice treated with ACE fraction.
Animal studies demonstrate antiulcerogenic and anti-gastric secretion activity of A. calamus extract. Traditional Ayurvedic and Unani systems reference its use in gastric complaints that overlap with ulcer presentation. No human RCT data on peptic ulcer are available.
A. calamus is one of the most widely documented traditional remedies for abdominal discomfort, including gas, bloating, colic, and cramping, across Ayurveda, Chinese medicine, Unani, and Native American traditions. Its antispasmodic (calcium channel blocking) and carminative properties are pharmacologically supported.
A. calamus is traditionally used as an appetite stimulant in Ayurveda, Unani, and multiple folk medicine traditions, listed explicitly for 'appetite loss' among its indications. Its bitter aromatic constituents mechanistically support digestive and appetite stimulation. No human appetite trials exist.
A. calamus is used in Ayurveda and multiple traditional systems for rheumatism and arthritis, attributed to its anti-inflammatory and analgesic properties. Preclinical anti-inflammatory data support this use. Traditional references include use in rheumatoid arthritis, neuralgia, and joint pain, but no dedicated arthritis human trials exist.
Vacha is a classical Ayurvedic herb used specifically for children's attention, intellect, and speech development. It is included in Ayurvedic formulations being clinically trialled for ADHD, though evidence for Vacha alone in ADHD is based on traditional practice rather than standalone controlled trials.
Traditional use of A. calamus for bad breath and oral hygiene is documented in Unani and Ayurvedic traditions, attributed to its aromatic antimicrobial essential oil. The rhizome is used to 'treat mouth ulcers by preventing bleeding of the gums and bad breath' in Siddha and Unani systems.
A. calamus is traditionally used in bronchitis across Ayurveda, Chinese medicine, and multiple folk traditions, attributed to its expectorant, antispasmodic, and anti-inflammatory properties. Bronchodilatory activity is confirmed preclinically. Traditional classification as an expectorant appears consistently across pharmacopeial references.
A. calamus rhizome has been used in Indian, South Asian, and African traditional medicine specifically for infant and childhood colic and related gastrointestinal distress. Antispasmodic activity in smooth muscle provides pharmacological plausibility. No clinical trials in infants have been identified.
A. calamus is documented as a laxative in traditional Chinese medicine, Ayurveda, and Unani systems. Charaka classified it as an adjunct to decoction enemas. Chinese traditional use for 'lessening swelling and constipation' is specifically recorded.
Eczema and skin diseases are explicitly listed among traditional treatment indications for A. calamus across multiple documented sources. Anti-inflammatory, antimicrobial, and antioxidant properties provide mechanistic support. No clinical trials in eczema exist.
Fever is among the most consistently listed traditional indications for A. calamus across Ayurveda, Unani, and Chinese medicine. The plant is used in intermittent fevers and febrile convulsions in children. Antipyretic activity is supported by preclinical data documenting anti-inflammatory and antipyretic properties.
Vacha (A. calamus) has a strong traditional reputation across Ayurveda and multiple ethnomedicinal systems as a mind-sharpening herb that increases attention and concentration. Preclinical data support CNS stimulant and cholinergic effects but clinical trials specifically targeting focus are lacking.
A. calamus has documented traditional use for headaches in Native American medicine and Ayurvedic medicine (where it is included among Vacha's CNS indications). Preclinical CNS analgesic effects and traditional pain-relief use are documented. No clinical trials exist.
Charaka Samhita classifies Vacha as arsoghna (anti-hemorrhoidal), making this among the most formally documented traditional indications in Ayurvedic pharmacopoeia. Its use for hemorrhoids appears in Ayurvedic texts spanning millennia. No clinical trial data exist.
A. calamus is listed in Ayurvedic pharmacology as sedative and CNS-depressant, with traditional use for insomnia and hysteria. Animal studies confirm sedative and hypnotic properties attributable to asarone components. No human clinical trials on insomnia as a primary outcome have been identified.
Vacha is classified as an expectorant and mucolytic across Ayurveda, Unani, and Chinese traditional medicine. It is listed as sirovirectana (cleansing nasal therapy) in Charaka Samhita. The aromatic volatile oils are proposed to thin and expel phlegm from the respiratory tract.
A. calamus has traditional use across Ayurveda, Unani, and Native American medicine for nausea and vomiting, particularly in the context of digestive disorders. It is listed in Unani texts as a stomach tonic and gastrointestinal remedy. No clinical trial data specific to nausea/vomiting exist.
A. calamus is classified as anthelmintic (krimighna) in Ayurveda and used with milk to dispel intestinal worms in South Indian and other traditions. Anthelmintic properties appear in multiple ethnomedicinal and pharmacopoeial references. No clinical anthelmintic trial data are available.
A. calamus is traditionally classified as sirovirectana (cleansing nasal therapy) in Ayurveda and used for sinusitis across multiple traditional systems. Decongestant and mucolytic mechanisms are attributed to its aromatic volatile oil. Traditional documentation of its use in sinusitis is consistent.
A. calamus rhizome has long traditional use for pharyngitis, hoarse voice, and sore throat across Ayurvedic, Unani, and South Asian folk medicine. Elderly use of the root chewed for pharyngitis is documented. Antimicrobial and anti-inflammatory activity provide mechanistic support.
Multiple traditional systems document A. calamus as a topical anesthetic for toothache, including Native American use and South Asian dental ethnobotany. Ethnobotanical notes on dental disorders from Tirumala Hills reference its use. The eugenol content provides pharmacological plausibility.
A. calamus has documented traditional use for wound healing as an antiseptic and vulnerary across multiple traditional systems, and in vitro antibacterial activity against wound pathogens (including MRSA) has been demonstrated. Traditional documentation includes use 'in healing cuts and wounds' with antiseptic properties.
Volver